Tredje AP fonden Acquires New Position in HCA Healthcare, Inc. $HCA

Tredje AP fonden bought a new stake in HCA Healthcare, Inc. (NYSE:HCAFree Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 13,112 shares of the company’s stock, valued at approximately $6,121,000.

A number of other institutional investors have also recently added to or reduced their stakes in HCA. Viking Global Investors LP grew its position in HCA Healthcare by 58.5% in the 2nd quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock valued at $717,214,000 after buying an additional 690,773 shares in the last quarter. Northwestern Mutual Wealth Management Co. boosted its holdings in shares of HCA Healthcare by 4,545.5% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 663,337 shares of the company’s stock valued at $309,686,000 after acquiring an additional 649,058 shares in the last quarter. Danske Bank A S bought a new stake in HCA Healthcare during the third quarter worth approximately $115,530,000. Zurich Insurance Group Ltd FI boosted its stake in HCA Healthcare by 3,755.9% during the 3rd quarter. Zurich Insurance Group Ltd FI now owns 269,912 shares of the company’s stock valued at $115,036,000 after purchasing an additional 262,912 shares in the last quarter. Finally, Mondrian Investment Partners LTD acquired a new stake in shares of HCA Healthcare in the third quarter valued at $106,605,000. 62.73% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on HCA shares. Wells Fargo & Company cut their price target on shares of HCA Healthcare from $481.00 to $436.00 and set an “equal weight” rating for the company in a report on Monday, April 27th. Truist Financial dropped their price target on HCA Healthcare from $546.00 to $535.00 and set a “buy” rating on the stock in a report on Monday, April 27th. Cantor Fitzgerald reiterated an “overweight” rating on shares of HCA Healthcare in a research report on Wednesday, March 4th. JPMorgan Chase & Co. decreased their target price on shares of HCA Healthcare from $535.00 to $490.00 and set a “neutral” rating for the company in a report on Tuesday. Finally, TD Cowen decreased their price objective on shares of HCA Healthcare from $561.00 to $500.00 and set a “buy” rating for the company in a research note on Monday, April 27th. Sixteen equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, HCA Healthcare has an average rating of “Moderate Buy” and a consensus price target of $515.77.

Read Our Latest Stock Report on HCA Healthcare

HCA Healthcare Trading Down 4.4%

HCA opened at $403.98 on Wednesday. The stock has a market cap of $89.62 billion, a price-to-earnings ratio of 13.89, a PEG ratio of 1.34 and a beta of 1.18. HCA Healthcare, Inc. has a 1 year low of $330.00 and a 1 year high of $556.52. The stock has a fifty day moving average price of $473.90 and a 200 day moving average price of $485.20.

HCA Healthcare (NYSE:HCAGet Free Report) last announced its quarterly earnings results on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing the consensus estimate of $7.19 by ($0.04). The firm had revenue of $19.11 billion during the quarter, compared to the consensus estimate of $19.09 billion. HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The company’s quarterly revenue was up 4.3% compared to the same quarter last year. During the same period in the previous year, the firm posted $6.45 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, sell-side analysts forecast that HCA Healthcare, Inc. will post 30.07 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th will be given a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a yield of 0.8%. The ex-dividend date of this dividend is Tuesday, June 16th. HCA Healthcare’s dividend payout ratio is presently 10.73%.

About HCA Healthcare

(Free Report)

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

See Also

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.